Whereas the serum levels of IgA, Gd-IgA1 and glycan-specific IgG are higher in patients with IgAN compared to healthy controls, the levels of these parameters have not been systematically studied in patients with other forms renal disease with clinical features similar to those of IgAN. This evidence concerns the gene CD79A and kidney disorder.